|
Ataxia-Telangiectasia (AT)
|
ATM 11q23
|
P041-ATM-1
|
€ 1145
|
|
Ataxia-Telangiectasia (AT)
|
ATM 11q23
|
P042-ATM-2
|
€ 1145
|
|
Breast cancer
|
BRCA1 region
|
P239-BRCA1 region
|
€ 1145
|
|
Breast cancer susceptibility
|
CHEK2 22q12, ATM , PTEN, TP53
|
P190-CHEK2
|
€ 1145
|
|
Breast cancer, hereditary
|
BRCA2 13q12.3
|
P090-BRCA2
|
€ 1145
|
|
Breast cancer, hereditary
|
BRCA2, CHEK2
|
P045-BRCA2
|
€ 1145
|
|
Breast cancer, hereditary
|
BRCA2
|
P077-BRCA2
|
€ 1145
|
|
Breast cancer, hereditary
|
BRCA1
|
P087-BRCA1
|
€ 1145
|
|
Breast cancer, hereditary
|
BRCA1, 17q21
|
P002-BRCA1
|
€ 1145
|
|
CDH1 or E-cadherin
|
CDH1 16q22.1
|
P083-CDH1
|
€ 1145
|
|
Cancer
|
BRIP1 17q22, CHEK1 11q22
|
P240-BRIP1/CHEK1
|
€ 1145
|
|
Cancer
|
PTEN 10q23
|
P225-PTEN
|
€ 1145
|
|
Colon cancer, hereditary non-polyposis (HNPCC)
|
MLH1 3p21.3, MSH2 2p21
|
P248-MLH1-MSH2
|
€ 1145
|
|
Fanconi anemia complementation group B
|
FANCB Xp22
|
P113-FANCB
|
€ 1145
|
|
Gorlin syndrome
|
PTCH 9q22.3
|
P067-Gorlin
|
€ 1145
|
|
Hereditary Polyposis Colon Cancer
|
APC, 5q21-q22
|
P043-APC
|
€ 1145
|
|
Hereditary nonpolyposis colon cancer (HNPCC)
|
MLH1 3p21.3, MSH2 2p22
|
P003-MLH1/MSH2
|
€ 1145
|
|
Hereditary nonpolyposis colon cancer (HNPCC)
|
MSH6 2p16, PMS2 7p22
|
P008-PMS2/MSH6
|
€ 1145
|
|
Hereditary nonpolyposis colon cancer (HNPCC)
|
MSH6
|
P072-MSH6
|
€ 1145
|
|
Juvenile polyposis syndrome (JPS)
|
BMPR1A 10q22, SMAD4 18q21, PTEN
|
P158-JPS
|
€ 1145
|
|
Li-Fraumeni syndrome (LFS)
|
P53 17q13.1
|
P056-TP53
|
€ 1145
|
|
Multiple Osteochondromas
|
EXT1 8q24, EXT2 11p12
|
P215-EXT
|
€ 1145
|
|
Neurofibromatosis
|
NF1 17q11.2
|
P122-NF1-area
|
€ 1145
|
|
Neurofibromatosis
|
NF1 17q11.2
|
P081-NF1 mix 1
|
€ 1145
|
|
Neurofibromatosis
|
NF1 17q11.2
|
P082-NF1 mix 2
|
€ 1145
|
|
Neurofibromatosis type 2 (NF2)
|
NF2 22q12
|
P044-NF2improved
|
€ 1145
|
|
Paragangliomas (PGL)
|
SDHD 11q23.1, SDHB 1p36.1, SDHC 1q23.3
|
P226-SDHD
|
€ 1145
|
|
Peutz-jeghers syndrome (PJS)
|
STK11 19p13.3
|
P101-STK11
|
€ 1145
|
|
Retinoblastoma (RB)
|
RB1 13q14
|
P047-RB1
|
€ 1145
|
|
Rhabdoid tumors
|
SMARCB1 22q11.2
|
P258-SMARCB1
|
€ 1145
|
|
Tumours, Cutaneous melanoma
|
9p21, CDKN2A, CDKNA2B
|
ME024-9p21
|
€ 1145
|
|
Von Hippel-Lindau Syndrome
|
VHL, 3p25
|
P016-VHL
|
€ 1145
|
|
Wilms tumours, WAGR, Denys-Drash, Frasier syndrome.
|
WT1 11p13
|
P118-WT1
|
€ 1145
|